Enlivex Therapeutics Ltd. - ENLV

About Gravity Analytica
Recent News
- 02.10.2026 - Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange
- 01.26.2026 - Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
- 01.23.2026 - Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
- 01.07.2026 - Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
- 12.04.2025 - Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Recent Filings
- 02.05.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 02.05.2026 - EX-99.1 EX-99.1
- 01.26.2026 - EX-99.1 EX-99.1
- 01.26.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 01.23.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 01.23.2026 - EX-99.1 EX-99.1
- 01.07.2026 - EX-99.1 EX-99.1
- 01.07.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 01.06.2026 - 424B3 Prospectus [Rule 424(b)(3)]
- 01.02.2026 - EFFECT Notice of Effectiveness